Physician drug prescribing preferences and availability for ventilation of patients with COVID-19
File version
Author(s)
Dooley, MJ
Townsend, S
Carmichael, S
Poole, SG
Karamujic, N
Richards, B
Ziegenfuss, M
Ankravs, MJ
Uren, H
Roberts, JA
Holley, A
Griffith University Author(s)
Primary Supervisor
Other Supervisors
Editor(s)
Date
Size
File type(s)
Location
License
Abstract
The coronavirus disease 2019 (COVID-19) pandemic has overwhelmed many international health care systems, with a high number of patients having severe respiratory failure.1,2 The mainstay of treatment for these patients is invasive mechanical ventilation requiring pharmacological induction, followed by ongoing sedation and analgesia.3-5 In the setting of severe acute respiratory failure, neuromuscular blockade is often required.
Journal Title
Critical care and resuscitation
Conference Title
Book Title
Edition
Volume
22
Issue
3
Thesis Type
Degree Program
School
DOI
Patent number
Funder(s)
Grant identifier(s)
Rights Statement
Rights Statement
Item Access Status
Note
Access the data
Related item(s)
Subject
Clinical sciences
Nursing
Persistent link to this record
Citation
Coombes, ID; Dooley, MJ; Townsend, S; Carmichael, S; Poole, SG; Karamujic, N; Richards, B; Ziegenfuss, M; Ankravs, MJ; Uren, H; Roberts, JA; Holley, A, Physician drug prescribing preferences and availability for ventilation of patients with COVID-19, Critical care and resuscitation, 2020, 22 (3), pp. 271-274